Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis.

Rheumatology (Oxford, England) - 1 Apr 2015

Vigone Barbara, Santaniello Alessandro, Marchini Maurizio, Montanelli Gaia, Caronni Monica, Severino Adriana, Beretta Lorenzo

Abstract excerpt

OBJECTIVE: HLAs have been extensively associated with SSc susceptibility but their role in the progression of the disease is poorly understood. In 2013 the ACR and European League Against Rheumatism (EULAR) jointly defined criteria for the classification of SSc that allow the early identification of definite SSc patients. In this study we investigated the role of HLA class II antigens in the progression from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histocompatibility Antigens Class II
Share to HLA-D Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DQ alpha-Chains

Share to HLA-DQ Antigens

Share to HLA-DQ beta-Chains

Share to HLA-DRB1 Chains

Share to Proportional Hazards Models

Share to Scleroderma, Systemic

Source

Identifiers

PMID: 25231181
DOI: 10.1093/rheumatology/keu381

Genes

ACR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis.PMID 25231181Read ↗

Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey.Semantic proximity Read ↗

Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors.Semantic proximity Read ↗

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.Semantic proximity Read ↗

Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.Semantic proximity Read ↗

Clinical and genetic factors predictive of mortality in early systemic sclerosis.Semantic proximity Read ↗

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.Semantic proximity Read ↗

Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets.Semantic proximity Read ↗

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease.Semantic proximity Read ↗

Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.Semantic proximity Read ↗

HLA markers for susceptibility and expression in scleroderma.Semantic proximity Read ↗

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.Semantic proximity Read ↗

HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.